Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Intravenous Immunoglobulin Market, by Distribution Channel
1.4.2 North America Intravenous Immunoglobulin Market, by Application
1.4.3 North America Intravenous Immunoglobulin Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Intravenous Immunoglobulin Market by Distribution Channel
3.1 North America Hospital Pharmacy Market by Country
3.2 North America Specialty Pharmacy Market by Country
3.3 North America Others Market by Country
Chapter 4. North America Intravenous Immunoglobulin Market by Application
4.1 North America Immunodeficiency Diseases Market by Country
4.2 North America Chronic Inflammatory Demyelinating Polyneuropathy Market by Country
4.3 North America Hypogammaglobulinemia Market by Country
4.4 North America Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country
4.5 North America Congenital AIDS & Multifocal Motor Neuropathy Market by Country
4.6 North America Kawasaki Disease Market by Country
4.7 North America Guillain-Barre Syndrome Market by Country
4.8 North America Immune thrombocytopenia (ITP) Market by Country
4.9 North America Others Market by Country
Chapter 5. North America Intravenous Immunoglobulin Market by Country
5.1 US Intravenous Immunoglobulin Market
5.1.1 US Intravenous Immunoglobulin Market by Distribution Channel
5.1.2 US Intravenous Immunoglobulin Market by Application
5.2 Canada Intravenous Immunoglobulin Market
5.2.1 Canada Intravenous Immunoglobulin Market by Distribution Channel
5.2.2 Canada Intravenous Immunoglobulin Market by Application
5.3 Mexico Intravenous Immunoglobulin Market
5.3.1 Mexico Intravenous Immunoglobulin Market by Distribution Channel
5.3.2 Mexico Intravenous Immunoglobulin Market by Application
5.4 Rest of North America Intravenous Immunoglobulin Market
5.4.1 Rest of North America Intravenous Immunoglobulin Market by Distribution Channel
5.4.2 Rest of North America Intravenous Immunoglobulin Market by Application
Chapter 6. Company Profiles
6.1 Grifols, S.A
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional & Segmental Analysis
6.1.4 Research & Development Expenses
6.1.5 Recent strategies and developments:
6.1.5.1 Product Launches and Product Expansions:
6.1.5.2 Acquisition and Mergers:
6.2 Takeda Pharmaceutical Company Limited
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Approvals and Trials:
6.3 Baxter International, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Regional Analysis
6.3.4 Research & Development Expense
6.4 Biotest AG (Tiancheng International Investment Limited)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.5 LFB S.A.
6.5.1 Company Overview
6.5.2 Recent strategies and developments:
6.5.2.1 Partnerships, Collaborations, and Agreements:
6.6 CSL Limited (CSL Behring)
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 Octapharma AG
6.7.1 Company Overview
6.7.2 Recent strategies and developments:
6.7.2.1 Approvals and Trials:
6.8 Kedrion S.p.A
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expenses
6.9 Bayer AG
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expense
Unique Offerings 